Bibliographie (2528)
Multisystem effects of COVID-19: A concise review for practitioners
mercredi, 16 septembre 2020 11:49 Écrit par Zouhair SouissiMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
The post Multisystem effects of COVID-19: A concise review for practitioners appeared first on Links Medicus.
COVID-19: Guidance on palliative care from a European Respiratory Society international task force
mercredi, 16 septembre 2020 11:49 Écrit par Zouhair SouissiCOVID-19: guidance on palliative care from a European Respiratory Society international task force – European Respiratory Journal
The post COVID-19: Guidance on palliative care from a European Respiratory Society international task force appeared first on Links Medicus.
The lasting misery of coronavirus long-haulers
mardi, 15 septembre 2020 13:18 Écrit par Zouhair SouissiThe lasting misery of coronavirus long-haulers – Nature
The post The lasting misery of coronavirus long-haulers appeared first on Links Medicus.
NIH launches two trials to test blood thinners in COVID-19 patients
mardi, 15 septembre 2020 13:18 Écrit par Zouhair SouissiNIH launches two trials to test blood thinners in COVID-19 patients – Reuters
The post NIH launches two trials to test blood thinners in COVID-19 patients appeared first on Links Medicus.
Viewpoint: COVID-19 and the path to immunity
lundi, 14 septembre 2020 05:05 Écrit par Zouhair SouissiCOVID-19 and the Path to Immunity – JAMA Commentary on Twitter Declines in SARSCoV2 IgG neutralizing Abs raise concerns of susceptibility to reinfection. But acute Ab levels always decline post-infection, and Ab recall responses come from a pool of long-lived memory B cells https://t.co/geGOQkhdw2 — JAMA (@JAMA_current) September 12, 2020
The post Viewpoint: COVID-19 and the path to immunity appeared first on Links Medicus.
COVID-19 herd immunity: Where are we?
lundi, 14 septembre 2020 05:05 Écrit par Zouhair SouissiCOVID-19 herd immunity: where are we? – Nature Reviews Immunology Commentary on Twitter This is one of the most succinct and best written short pieces on herd immunity, what it is and where we are heading with #COVID19. If not comfortable with math, just get through the first sentences and it’s worth continuing the […]
The post COVID-19 herd immunity: Where are we? appeared first on Links Medicus.
Meta-analysis: PEEP-induced recruited lung volume measured by volume-pressure curves in ARDS
lundi, 14 septembre 2020 03:05 Écrit par Zouhair SouissiPositive end-expiratory pressure-induced recruited lung volume measured by volume-pressure curves in acute respiratory distress syndrome: a physiologic systematic review and meta-analysis – Intensive Care Medicine Commentary on Twitter PEEP-induced recruited lung volume measuredby VP curves in #ARDS, systematic review: after PEEP increment most pts are recruiters (Vrec > 150ml, 74%). #ICU mortality no significantly […]
The post Meta-analysis: PEEP-induced recruited lung volume measured by volume-pressure curves in ARDS appeared first on Links Medicus.
A COVID-19 vaccine may be only 50% effective. Is that good enough?
lundi, 14 septembre 2020 03:05 Écrit par Zouhair SouissiA COVID-19 Vaccine May Be Only 50% Effective. Is That Good Enough? – NPR
The post A COVID-19 vaccine may be only 50% effective. Is that good enough? appeared first on Links Medicus.
Updated meta-analysis: Drug treatments for Covid-19
lundi, 14 septembre 2020 03:05 Écrit par Zouhair SouissiDrug treatments for covid-19: living systematic review and network meta-analysis – The BMJ Commentary on Twitter Our first update of our living NMA on treatments for covid-19 is published today: https://t.co/xRiSBkuRyG#COVID19 — ReedSiemieniuk. (@RSiemieniuk) September 11, 2020
The post Updated meta-analysis: Drug treatments for Covid-19 appeared first on Links Medicus.
Preliminary randomized trial evaluated recombinant human granulocyte colony–stimulating factor for patients with COVID-19 and lymphopenia
vendredi, 11 septembre 2020 11:09 Écrit par Zouhair SouissiEffect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial – JAMA Internal Medicine Invited Commentary: Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)—Beware of Blind Spots Commentary on Twitter Preliminary findings from a randomized clinical trial suggest that […]
The post Preliminary randomized trial evaluated recombinant human granulocyte colony–stimulating factor for patients with COVID-19 and lymphopenia appeared first on Links Medicus.
